The Dimension Vista® 500 System provides intelligent analytics where sample-centric design, unique integration of four technologies, including LOCI® advanced chemiluminescence, customer-driven engineering and flexibility of configurations all come together for a more efficient workflow.
- Sample-centric design incorporates Lean principles for simplified, consolidated sample processing
- Unique integration of four technologies allows simultaneous processing of tests for multiple disease states on a single platform from a single tube
- Customer-driven engineering helps eliminate many manual tasks freeing up technical time to address critical issues throughout the lab
- Flexibility of configurations to meet your laboratory needs today and into the future
High-Sensitivity Troponin I
Drugs of Abuse/Toxicology
EDDP (Methadone Metabolite)†
Ethyl Glucuronide (EtG)†,**
Alanine Aminotransferase (ALT)
Alkaline Phosphatase (ALP)
Gamma Glutamyltransferase (GGT)
Total Iron Binding Capacity
Total Protein, CSF/Urine
Urea Nitrogen (BUN)
Cyclosporine (Extended Range)‡
Special Infectious Disease
Antistreptolysin O (ASO)
Ig Light Chains, Type Kappa
Ig Light Chains, Type Lambda
IgG Subclass 1
IgG Subclass 2
IgG Subclass 3
IgG Subclass 4
Retinol Binding Protein
Rheumatoid Factor (RF)
Soluble Transferrin Receptor (sTfR)
Therapeutic Drug Monitoring (TDM)
1,855 lb (841.41 kg)
Width: 84 ¾” (215.3 cm)
Did this information help you?
* Not available for sale in the U.S.
† Alliance Application manufactured by third party, distributed by Siemens Healthcare Diagnostics.
‡ No manual pre-treatment.
§ Alliance Application manufactured and distributed by Siemens Healthcare Diagnostics.
** Restricted in the U.S. to law enforcement-related use (forensic use only).
†† This test has not been FDA-cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for detecting the presence of antibodies against SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Product availability may vary by country and is subject to regulatory requirements.
The products/features (mentioned herein) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.